Role of gut microbiota-derived metabolites on vascular calcification in CKD

J Cell Mol Med. 2021 Feb;25(3):1332-1341. doi: 10.1111/jcmm.16230. Epub 2020 Dec 27.

Abstract

The interaction between gut microbiota and the host has gained widespread concern. Gut microbiota not only provides nutrients from the ingested food but also generates bioactive metabolites and signalling molecules to impact host physiology, especially in chronic kidney disease (CKD). The development of CKD, accompanied by changed diet and medication, alters the gut flora and causes the effect in distant organs, leading to clinical complications. Vascular calcification (VC) is an actively regulated process and a high prevalence of VC in CKD has also been linked to an imbalance in gut microbiota and altered metabolites. In this review, we focused on gut microbiota-derived metabolites involved in VC in CKD and explained how these metabolites influence the calcification process. Correcting the imbalance of gut microbiota and regulating microbiota-derived metabolites by dietary modification and probiotics are new targets for the improvement of the gut-kidney axis, which indicate innovative treatment options of VC in CKD.

Keywords: chronic kidney disease; gut microbiota-derived metabolites; vascular calcification.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bile Acids and Salts / metabolism
  • Biomarkers
  • Diet
  • Disease Management
  • Disease Susceptibility*
  • Gastrointestinal Microbiome*
  • Host Microbial Interactions*
  • Humans
  • Lipid Metabolism
  • Renal Insufficiency, Chronic / etiology*
  • Renal Insufficiency, Chronic / metabolism*
  • Renal Insufficiency, Chronic / pathology
  • Renal Insufficiency, Chronic / therapy
  • Vascular Calcification / etiology*
  • Vascular Calcification / metabolism*
  • Vascular Calcification / pathology
  • Vascular Calcification / therapy

Substances

  • Bile Acids and Salts
  • Biomarkers